Cargando…
Comparison of Long-Term Oncologic Outcomes Between Surgical T4 and T3 in Patients Diagnosed With Pathologic Stage IIA Right Colon Cancer
PURPOSE: T stage plays an important role in the classification of subgroups in stage II colon cancer. Patients with pathologic T4 are at high risk of recurrence and it is recommended to include adjuvant chemotherapy in the treatment plan, while this is not necessary in pathologic T3. There is a disc...
Autores principales: | Jeon, Youngbae, Nam, Kug Hyun, Choi, Seok Won, Hwang, Tae Sik, Baek, Jeong-Heum |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334016/ https://www.ncbi.nlm.nih.gov/pubmed/35912269 http://dx.doi.org/10.3389/fonc.2022.931414 |
Ejemplares similares
-
Ground Glass Opacity and Adjuvant Chemotherapy in Pathological Stage IB–IIA Lung Adenocarcinoma
por: Zhai, Wenyu, et al.
Publicado: (2022) -
Radical surgery for stage IB2/IIA2 cervical cancer: A large retrospective study
por: Zhou, Fang, et al.
Publicado: (2022) -
Evaluating the Guiding Role of Elevated Pretreatment Serum Carcinoembryonic Antigen Levels for Adjuvant Chemotherapy in Stage IIA Colon Cancer: A Large Population-Based and Propensity Score-Matched Study
por: Liu, Qi, et al.
Publicado: (2019) -
Long-term Survival, Tolerability, and Safety of First-Line
Bevacizumab and FOLFIRI in Combination With Ginsenoside-Modified Nanostructured
Lipid Carrier Containing Curcumin in Patients With Unresectable Metastatic
Colorectal Cancer
por: Jeon, Youngbae, et al.
Publicado: (2022) -
Transformation of Pathology Reports Into the Common Data Model With Oncology Module: Use Case for Colon Cancer
por: Ryu, Borim, et al.
Publicado: (2020)